Journey Medical's new rosacea treatment will rival industry giant Galderma's Oracea in the treatment of rosacea.

Fortress Biotech, Inc. (NASDAQ: FBIO) announced through its majority-controlled subsidiary, Journey Medical Corporation, that the U.S. Food and Drug Administration (FDA) has approved Emrosi™ ...

As demand for popular weight-loss drugs like Wegovy and Zepbound skyrockets, patients are taking dosage amounts into their ...

Key trial focus: PK/PD in healthy subjects, with PK bracketed by standard epinephrine injections No placebo-controlled efficacy studies required NORTH HAVEN, Conn., Nov. 05, 2024 (GLOBE NEWSWIRE) -- ...

On November 1, Nanjing Leads Biolabs Co., Ltd. (hereinafter referred to as “Leads Biolabs”) announced that LBL-034, a humanized bispecific T-cell engaging antibody targeting both GPRC5D and CD3 which ...

While Ozempic has been shown to lead to weight loss as a side effect, it's not without risks. According to the Cleveland ...

Americans await the results as citizens across the nations cast their final votes on Election Day. Donald Trump ...

Journey Medical has claimed FDA approval for its Emrosi therapy for rosacea, which it thinks could become a "standard of care ...

In the ever-evolving world of wellness and self-care, finding the right supplement can sometimes feel like searching for a ...

The FDA approved Emrosi (minocycline hydrochloride extended-release capsules) for the treatment of inflammatory lesions of rosacea in adults.

“You’re sharing your trauma journey ... was not using the drug to treat a mental health problem, Ghaemi said many are seeking ...

Analyst Jason Butler from JMP Securities reiterated a Buy rating on Aquestive Therapeutics (AQST – Research Report) and keeping the price ...